# Challenges in employing overall survival as a primary outcome in ovarian cancer studies: insights from PARP inhibitor trials

**Authors:** Yoav Siegler, Emad Matanes

PMC · DOI: 10.3389/fonc.2026.1803208 · 2026-03-11

## Full-text entities

- **Genes:** PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142] {aka ADPRT, ADPRT 1, ADPRT1, ARTD1, PARP, PARP-1}
- **Diseases:** ovarian cancer (MESH:D010051)

---
Source: https://tomesphere.com/paper/PMC13013530